MicroPort Scientific Announces Potential Spin-off and Independent Listing of MicroPort CardioFlow Medtech Corporation
MicroPort
High-end Medical Device R&D and Manufacturer
MicroPort CardioFlow
A Provider of High-End Interventional Medical Devices in the Cardiac Valve Field, Engaged in R&D, Manufacturing, Sales, and Related Technical Consulting Services
MicroPort Medical(00853) announced that the Company is considering a possible spin-off and separate listing of the shares of its non-wholly owned subsidiary, MicroPort CardioFlow Medtech Corporation (MicroPort CardioFlow), on a recognized stock exchange.
It is reported that MicroPort CardioFlow and its subsidiaries are engaged in the development of devices primarily for the treatment of structural heart diseases, with a focus on valvular heart disease.
As of the date of this announcement, the details of the proposed spin-off and listing have not been finalized. Shareholders of the Company and potential investors are advised to note that the proposed spin-off and listing are subject to market conditions and approval from the relevant regulatory authorities. There is no assurance that the proposed spin-off and listing will proceed or as to when they will take place. Holders of the Company’s shares and potential investors are urged to exercise caution when dealing in the securities of the Company.